Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00624351
What this trial is testing

Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 227
Not applicableActive Not RecruitingNCT06479213
What this trial is testing

REACH (Restore Energy, Activity Can Help) Lupus Study

Who this might be right for
Systemic Lupus ErythematosusFatigue
Tufts Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00000421
What this trial is testing

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 154
Not applicableStudy completedNCT03144063
What this trial is testing

Improving the Assessment of SLE Disease Activity

Who this might be right for
Lupus Erythematosus, SystemicSLE
University Health Network, Toronto 247
Testing effectiveness (Phase 2)Study completedNCT03161483
What this trial is testing

Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Celgene 289
Large-scale testing (Phase 3)Active Not RecruitingNCT05138133
What this trial is testing

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 363
Early research (Phase 1)Looking for participantsNCT07109986
What this trial is testing

UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Nanjing IASO Biotechnology Co., Ltd. 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767188
What this trial is testing

A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)

Who this might be right for
Lupus Nephritis
Zhao Minghui 70
Not applicableLooking for participantsNCT06394063
What this trial is testing

Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 176
Not applicableStudy completedNCT02769195
What this trial is testing

Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE

Who this might be right for
Systemic Lupus Erythematosus
Monash University 1,684
Testing effectiveness (Phase 2)Ended earlyNCT04680637
What this trial is testing

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Active Systemic Lupus Erythematosus
Amgen 168
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Early research (Phase 1)Looking for participantsNCT07629583
What this trial is testing

To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

Who this might be right for
Lupus Erythematosus, Systemic
Genentech, Inc. 46
Not applicableNot Yet RecruitingNCT07622251
What this trial is testing

The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus

Who this might be right for
System Lupus Erythematosus(SLE)
Istanbul Galata University 38
Large-scale testing (Phase 3)Enrolling By InvitationNCT05352919
What this trial is testing

Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Biogen 864
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Not applicableNot Yet RecruitingNCT06872086
What this trial is testing

Assessment of Blood Indices in Systemic Lupus Erythematosus

Who this might be right for
SLEBlood Indices
Assiut University 70
Not applicableLooking for participantsNCT06166199
What this trial is testing

Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Karolinska Institutet 40
Not applicableUnknownNCT05261529
What this trial is testing

Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Universidad de Granada 90
Testing effectiveness (Phase 2)Study completedNCT04451772
What this trial is testing

The Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Who this might be right for
Systemic Lupus Erythematosus (SLE)
AbbVie 185
Next Page